Skip to main content
SpringerLink
Log in

Use of the Placebo Effect in the Psychotherapy of Narcology Patients: Therapeutic and Ethical Aspects

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

This review assesses the therapeutic potential of placebo and nocebo effects in the treatment of narcological disorders. The background of this issue is discussed and the neurobiological and psychological mechanisms of the placebo effect are addressed. Use of the placebo effect in psychotherapy is discussed. Particular attention is paid to the therapeutic and ethical aspects of the practical application of the placebo effect, including as part of treatment methods such as placebo therapy, object-oriented psychotherapy, motivational and cognitive behavioral psychotherapy, Antabuse treatment, and psychopharmacotherapy with opioid receptor antagonists. The authors conclude that placebo effects can be used in the treatment of narcological disorders with the aim of increasing efficacy, subject to compliance with the main principles of medical ethics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. E. Czerniak and M. Davidson, “Placebo, a historical perspective,” Eur. Neuropsychopharmacol., 22, No. 11, 770–774 (2012), doi: https://doi.org/10.1016/2012.04.003.

    Article  CAS  PubMed  Google Scholar 

  2. A. J. M. De Craen, T. J. Kaptchuk, J. G. P. Tijssen, and J. Kleijnen, “Placebos and placebo effects in medicine: historical overview,” J. Roy. Soc. Med., 92, 511–515 (1999).

    Article  PubMed  PubMed Central  Google Scholar 

  3. S. Stewart-Williams and J. Podd, “The placebo effect: dissolving the expectancy versus conditioning debate,” Psychol. Bull., 130, No. 2, 324–340 (2004), doi: https://doi.org/10.1037/0033-2909.130.2.324.

    Article  PubMed  Google Scholar 

  4. D. D. Price, D. G. Finniss, and F. Benedetti, “A comprehensive review of the placebo effect: recent advances and current thought,” Annu. Rev. Psychol., 59, No. 1, 565–590 (2008), doi: https://doi.org/10.1146/annurev.psych.59.113006.095941.

    Article  PubMed  Google Scholar 

  5. F. Benedetti, E. Carlino, and A. Pollo, “How placebos change the patient’s brain,” Neuropsychopharmacol. Rev., 36, 339–354 (2011), doi: https://doi.org/10.1038/npp.2010.81.

    Article  Google Scholar 

  6. I. Kirsch, “Placebo psychotherapy: Synonym or oxymoron?” J. Clin. Psychol., 61, No. 7, 791–803 (2005), doi: https://doi.org/10.1002/jclp.20126.

    Article  PubMed  Google Scholar 

  7. T. J. Kaptchuk, “Sham device v inert pill: randomised controlled trial of two placebo treatments,” Br. Med. J., 332, No. 7538, 391–397 (2006), doi: https://doi.org/10.1136/bmj.38726.603310.55.

    Article  Google Scholar 

  8. R. L. Waber, B. Shiv, Z. Carmon, and D. Ariely, “Commercial features of placebo and therapeutic efficacy, “ JAMA, 299, No. 9, 1016 (2008), doi: https://doi.org/10.1001/jama.299.9.1016.

    Article  CAS  PubMed  Google Scholar 

  9. M. Beauregard, “Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation., psychotherapy., and placebo effect,” Prog. Neurobiol., 81, No. 4, 218–236 (2007), doi: https://doi.org/10.1016/j.pneurobio.2007.01.005.

    Article  PubMed  Google Scholar 

  10. F. Benedetti, “The placebo response: science versus ethics and the vulnerability of the patient,” World Psychiatry, 11, No. 2, 70–72 (2012), doi: https://doi.org/10.1016/j.wpsyc.2012.05.003.

    Article  PubMed  PubMed Central  Google Scholar 

  11. F. Benedetti and M. Amanzio, “The placebo response: how words and rituals change the patient’s brain,” Patient Educ. Couns., 84, 413–419 (2011), doi: https://doi.org/10.1016/j.pec.2011.04.034.

    Article  PubMed  Google Scholar 

  12. H. K. Beecher, “The powerful placebo,” JAMA, 159, No. 17, 1602 (1955), doi: https://doi.org/10.1001/jama.1955.02960340022006.

    Article  CAS  Google Scholar 

  13. G. S. Kienle and H. Kiene, “The powerful placebo effect: fact or fiction?” J. Clin. Epidemiol., 50, No. 12, 1311–1318 (1997), doi: https://doi.org/10.1016/s0895-4356(97)00203-5.

    Article  CAS  PubMed  Google Scholar 

  14. J. Howick, C. Friedemann, M. Tsakok, et al., “Are treatments more effective than placebos? A systematic review and meta-analysis,” PLoS One, 8, No. 5, 62599 (2013), doi: https://doi.org/10.1371/journal.pone.0062599.

    Article  Google Scholar 

  15. F. Benedetti, “Placebo and the new physiology of the doctor-patient relationship,” Physiol. Rev., 93, No. 3, 1207–1246 (2013), doi: https://doi.org/10.1152/physrev.00043.2012.

    Article  PubMed  PubMed Central  Google Scholar 

  16. R. Kermen, J. Hickner, H. Brody, and I. Hasham, “Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos,” Fam. Med., 42, No. 9, 636–642 (2010).

    PubMed  Google Scholar 

  17. R. Sherman and J. Hickner, “Academic physicians use placebos in clinical practice and believe in the mind–body connection,” J. Gen. Int. Med., 23, No. 1, 7–10 (2007), doi: https://doi.org/10.1007/s11606-007-0332-z.

    Article  Google Scholar 

  18. B. E. Wampold, T. Minami, S. C. Tierney, et al., “The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials,” J. Clin. Psychol., 61, No. 7, 835–854 (2005), doi: https://doi.org/10.1002/jclp.20129.

    Article  PubMed  Google Scholar 

  19. T. P. Asay and M. J. Lambert, “The empirical case for the common factors in therapy: quantitative findings,” in: The Heart and Soul of Change: What Works in Therapy, M. A. Hubble et al. (eds.), American Psychological Association (APA), Washington D.C. (1999), pp. 23–55, doi: https://doi.org/10.1037/11132-001.

    Chapter  Google Scholar 

  20. “Recognition of psychotherapy effectiveness,” Psychotherapy, 50, No. 1, 102–109 (2013), doi: 10.1037/a0030276.

  21. A. Hrobjartsson and P. C. Gotzsche, “Placebo interventions for all clinical conditions,” Cochrane Database Syst. Rev., No. 1, CD003974 (2010), doi: 10.1002/14651858.CD003974.pub3.

  22. I. Kirsch, B. J. Deacon, T. B. Huedo-Medina, et al., “Initial severity and antidepressant benefi ts: a meta-analysis of data submitted to the Food and Drug Administration,” PLoS Medicine, 5, No. 2, 45 (2008), doi: https://doi.org/10.1371/journal.pmed.0050045.

    Article  Google Scholar 

  23. H. E. Pigott, A. M. Leventhal, G. S. Alter, and J. J. Boren, “Efficacy and effectiveness of antidepressants: current status of research,” Psychother. Psychosom., 79, No. 5, 267–279 (2010), doi: https://doi.org/10.1159/000318293.

    Article  PubMed  Google Scholar 

  24. J. C. Fournier, R. J. DeRubeis, S. D. Hollon, et al., “Antidepressant drug effects and depression severity,” JAMA, 303, No. 1, 47 (2010), doi: https://doi.org/10.1001/jama.2009.1943.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. W. Rief, Y. Nestoriuc, S. Weiss, et al., “Metaanalysis of the placebo response in antidepressant trials,” J. Affect. Disord., 118, No. 1–3, 1–8 (2009), doi: https://doi.org/10.1016/j.jad.2009.01.029.

    Article  CAS  PubMed  Google Scholar 

  26. K. N. Fountoulakis, A. Veroniki, M. Siamouli, and H-J. Moller, “No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis,” Ann. Gen. Psychiatry, 12, No. 1, 26 (2013), doi: https://doi.org/10.1186/1744-859x-12-26.

    Article  PubMed  PubMed Central  Google Scholar 

  27. T. W. Baskin, S. C. Tierney, T. Minami, and B. E. Wampold, “Establishing specificity in psychotherapy: A meta-analysis of structural equivalence of placebo controls,” J. Consult. Clin. Psychol., 71, No. 6, 973–979 (2003), doi: https://doi.org/10.1037/0022-006x.71.6.973.

    Article  PubMed  Google Scholar 

  28. J. D. Frank and J. A. Frank, Persuasion and Healing: a Comparative Study of Psychotherapy, Johns Hopkins Univ. Press, Baltimore (1991).

    Google Scholar 

  29. B. E. Wampold, “Humanism as a common factor in psychotherapy,” Psychotherapy, 49, No. 4, 445–449 (2012), doi: https://doi.org/10.1037/a0027113.

    Article  PubMed  Google Scholar 

  30. J. A. DeFife and M. J. Hilsenroth, “Starting off on the right foot: Common factor elements in early psychotherapy process,” J. Psychother. Integr., 21, No. 2, 172–191 (2011), doi: https://doi.org/10.1037/a0023889.

    Article  Google Scholar 

  31. S. Ekberg, R. K. Barnes, D. S. Kessler, et al., “Managing clients’ expectations at the outset of online cognitive behavioural therapy (CBT) for depression,” Health Expect. (2014), doi: https://doi.org/10.1111/hex.12227, http://onlinelibrary.wiley.com/DOI/10.1111/hex.12227/abstract, acc. Sept. 30, 2015.

  32. M. J. Constantino, C. R. Glass, D. B. Arnkoff, et al., “Expectations,” in: Psychotherapy Relationships That Work, J. C. Norcross (ed.), Oxford Univ. Press, New York (2011), doi: https://doi.org/10.1093/acprof:oso/9780199737208.003.0018.

    Google Scholar 

  33. M. J. Constantino, R. M. Ametrano, and R. P. Greenberg, “Clinician interventions and participant characteristics that foster adaptive patient expectations for psychotherapy and psychotherapeutic change,” Psychotherapy, 49, No. 4, 557–569 (2012), doi: https://doi.org/10.1037/a0029440.

    Article  PubMed  Google Scholar 

  34. K. Kuusisto, V. Knuuttila, and P. Saarnio, “Pre-treatment expectations in clients: impact on retention and effectiveness in outpatient substance abuse treatment,” Behav. Cogn. Psychother., 39, No. 3, 257–271 (2011), doi: https://doi.org/10.1017/s1352465810000846.

    Article  PubMed  Google Scholar 

  35. R. D. Weiss, S. S. O’Malley, J. D. Hosking, et al., “Do patients with alcohol dependence respond to placebo? Results from the COMBINE study,” J. Stud. Alcohol Drugs, 69, No. 6, 878–884 (2008), doi: https://doi.org/10.15288/jsad.2008.69.878.

    Article  PubMed  PubMed Central  Google Scholar 

  36. W. Hauser, E. Hansen, and P. Enck, “Nocebo phenomena in medicine: their relevance in everyday clinical practice,” Dtsch. Arztebl. Int., 109, No. 26, 459–465 (2012), doi: https://doi.org/10.3238/arztebl.2012.0459.

    PubMed  PubMed Central  Google Scholar 

  37. T. A. Furukawa, N. Watanabe, I. M. Omori, and R. Churchill, “Can pill placebo augment cognitive-behavior therapy for panic disorder?” BMC Psychiatry, 7, No. 1, 73 (2007), doi: https://doi.org/10.1186/1471-244x-7-73.

    Article  PubMed  PubMed Central  Google Scholar 

  38. A. C. Del Re, N. Maisel, J. C. Blodgett, et al., “Placebo group improvement in trials of pharmacotherapies for alcohol use disorders,” J. Clin. Psychopharmacol., 33, No. 5, 649–657 (2013), doi: https://doi.org/10.1097/jcp.0b013e3182983e73.

    Article  PubMed  PubMed Central  Google Scholar 

  39. F. G. Miller, L. Colloca, and T. J. Kaptchuk, “The placebo effect: illness and interpersonal healing,” Perspect. Biol. Med., 52, No. 4, 518–539 (2009), doi: https://doi.org/10.1353/pbm.0.0115.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lundh L-G., “The search for common factors in psychotherapy: two theoretical models with different empirical implications,” Psychol. Behav. Sci., 3, No. 5, 131 (2014), doi: https://doi.org/10.11648/j.pbs.20140305.11.

    Article  Google Scholar 

  41. G. M. Entin and S. G. Koporov, “The alcohol sign in Russia and the efficacy of a stress-mediated psychotherapy in the treatment of alcohol dependence syndrome,” Narkologiya, 11, 25–32 (2004).

    Google Scholar 

  42. E. M. Krupitskii, “Short-term intensive psychotherapeutic interventions in narcology from the point of view of evidence-based medicine,” Nevrol. Vestn., 3, 25–27 (2010).

    Google Scholar 

  43. T. J. O’Farrell and R. D. Bayog, “Antabuse contracts for married alcoholics and their spouses: A method to maintain antabuse ingestion and decrease conflict about drinking,” J. Subst. Abuse Treat., 3, No. 1, 1–8 (1986), doi: https://doi.org/10.1016/0740-5472(86)90002-4.

    Article  PubMed  Google Scholar 

  44. M. D. Skinner, P. Lahmek, H. Pham, and H-J. Aubin, “Disulfiram efficacy in the treatment of alcohol dependence: A meta-analysis,” PLoS One, 9, No. 2, 87366 (2014), doi: https://doi.org/10.1371/journal.pone.0087366.

    Article  Google Scholar 

  45. H. Krampe and H. Ehrenreich, “Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment,” Curr. Pharmaceut. Des., 16, No. 19, 2076–2090 (2010), doi: https://doi.org/10.2174/138161210791516431.

    Article  CAS  Google Scholar 

  46. F. Eippert, U. Bingel, E. D. Schoell, et al., “Activation of the opioidergic descending pain control system underlies placebo analgesia,” Neuron, 63, No. 4, 533–543 (2009), doi: https://doi.org/10.1016/j.neuron.2009.07.014.

    Article  CAS  PubMed  Google Scholar 

  47. A. V. Samokhvalov, I. Gamaleddin, B. Sproule, and J. Rehm, “Naltrexone may block euphoria-like placebo effect,” Br. Med. J., (2013); 2013010098-2013010098. doi: https://doi.org/10.1136/bcr-2013-010098.

  48. D. J. Drobes, R. F. Anton, S. E. Thomas, and K. Voronin, “Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers,” Alcohol. Clin. Exp. Res., 28, No. 9, 1362–1370 (2004), doi: https://doi.org/10.1097/01.alc.0000139704.88862.01.

    Article  CAS  PubMed  Google Scholar 

  49. P. A. Spagnolo, V. A. Ramchandani, M. L. Schwandt, et al., “Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients,” Alcohol Clin. Exp. Res., 38, No. 12, 3024–3032 (2014), doi: https://doi.org/10.1111/acer.12581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. M. Lieb, U. Palm, S. Chiang, et al., “Pharmacological challenge with naloxone and cue exposure in alcohol dependence: results of a randomized, double-blind placebo-controlled trial,” World J. Biol. Psychiatry, 14, No. 7, 539–546 (2013), doi: https://doi.org/10.3109/15622975.2013.812239.

    Article  PubMed  Google Scholar 

  51. W. R. Miller and S. Rollnick, Motivational Interviewing: Preparing People to Change Addictive Behavior, Guilford Press, New York (1991).

    Google Scholar 

  52. J. Klimas, H. Tobin, C-A Field, et al., “Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users,” Syst. Rev., 12, (2013), doi: https://doi.org/10.1002/14651858.CD009269.pub3.

  53. S. W. Feldstein Ewing, F. M. Filbey, A. Sabbineni, et al., “How psycho social alcohol interventions work: A preliminary look at what fMRI can tell us,” Alcohol Clin. Exp. Res., 35, No. 4, 643–651 (2011), doi: https://doi.org/10.1111/j.1530-0277.2010.01382.x.

    Article  PubMed  PubMed Central  Google Scholar 

  54. S. W. Feldstein Ewing, F. M. Filbey, C. S. Hendershot, et al., “Proposed model of the neurobiological mechanisms underlying psychosocial alcohol interventions: the example of motivational interviewing,” J. Stud. Alcohol Drugs, 72, No. 6, 903–916 (2011), doi: https://doi.org/10.15288/jsad.2011.72.903.

    Article  PubMed  PubMed Central  Google Scholar 

  55. L. H. Glynn and T. B. Moyers, “Chasing change talk: the clinician’s role in evoking client language about change,” J. Subst. Abuse Treat., 39, 65–70 (2010), doi: https://doi.org/10.1016/j.jsat.2010.03.012.

    Article  PubMed  Google Scholar 

  56. H. A. Westra, A. Aviram, M. Barnes, and L. Angus, “Therapy was not what I expected: A preliminary qualitative analysis of concordance between client expectations and experience of cognitive-behavioural therapy,” Psychother. Res., 20, No. 4, 436–446 (2010), doi: https://doi.org/10.1080/10503301003657395.

    Article  PubMed  Google Scholar 

  57. T. J. Kaptchuk, E. Friedlander, J. M. Kelley, et al., “Placebos without deception: a randomized controlled trial in irritable bowel syndrome,” PLoS One, 5, No. 12, e15591 (2010), doi: https://doi.org/10.1371/journal.pone.0015591.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. M. Srisurapanont and N. Jarusuraisin, “Opioid antagonists for alcohol dependence,” Cochrane Database Syst Rev, 1, CD001867 (2005), doi: https://doi.org/10.1002/14651858.CD001867.pub2.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Russian Peoples Friendship University, Moscow, Russia

    O. D. Tuchina, T. V. Agibalova, O. Zh. Buzik & Yu. E. Petrosyan

  2. Serbskii Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia

    T. V. Agibalova

  3. Pavlov Ryazan State Medical University, Ryazan, Russia

    D. I. Shustov & S. A. Shustova

Authors
  1. O. D. Tuchina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. V. Agibalova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. I. Shustov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. A. Shustova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. Zh. Buzik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yu. E. Petrosyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 116, No. 11, Iss. 2, Addictive Disorder, pp. 61–68, November, 2016.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tuchina, O.D., Agibalova, T.V., Shustov, D.I. et al. Use of the Placebo Effect in the Psychotherapy of Narcology Patients: Therapeutic and Ethical Aspects. Neurosci Behav Physi 48, 392–398 (2018). https://doi.org/10.1007/s11055-018-0576-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-018-0576-6

Keywords

Search

Navigation